Dahlöf B[Author] - Search Results

Year	Number of Results
1983	4
1984	2
1985	2
1986	5
1987	5
1988	6
1989	3
1990	5
1991	7
1992	15
1993	10
1994	6
1995	3
1996	3
1997	4
1998	7
1999	8
2000	11
2001	16
2002	21
2003	13
2004	29
2005	30
2006	13
2007	21
2008	27
2009	23
2010	24
2011	23
2012	22
2013	15
2014	12
2015	8
2016	4
2017	2
2018	1
2021	1
2023	1
2024	1
2025	0

1

CS1, a controlled-release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.

Benza RL, Adamson PB, Bhatt DL, Frick F, Olsson G, Bergh N, Dahlöf B. Benza RL, et al. Among authors: dahlof b. Pulm Circ. 2024 Jan 3;14(1):e12323. doi: 10.1002/pul2.12323. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38174159 Free PMC article.

2

The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptor.

Stanger L, Yamaguchi A, Yalavarthi P, Lambert S, Gilmore D, Rickenberg A, Luke C, Kumar K, Obi AT, White A, Bergh N, Dahlöf B, Holinstat M. Stanger L, et al. Among authors: dahlof b. Blood. 2023 Nov 2;142(18):1556-1569. doi: 10.1182/blood.2023020622. Blood. 2023. PMID: 37624927 Free PMC article.

3

Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension.

Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber MA, Jamerson KA. Brook RD, et al. Among authors: dahlof b. Am J Hypertens. 2021 May 22;34(5):531-539. doi: 10.1093/ajh/hpaa192. Am J Hypertens. 2021. PMID: 33216879

4

Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.

Brook RD, Kaciroti N, Bakris G, Dahlöf B, Pitt B, Velazquez E, Weber M, Zappe DH, Hau T, Jamerson KA. Brook RD, et al. Among authors: dahlof b. J Am Heart Assoc. 2018 Jan 4;7(1):e006940. doi: 10.1161/JAHA.117.006940. J Am Heart Assoc. 2018. PMID: 29301757 Free PMC article.

5

Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase.

Gupta A, Thompson D, Whitehouse A, Collier T, Dahlof B, Poulter N, Collins R, Sever P; ASCOT Investigators. Gupta A, et al. Among authors: dahlof b. Lancet. 2017 Jun 24;389(10088):2473-2481. doi: 10.1016/S0140-6736(17)31075-9. Epub 2017 May 2. Lancet. 2017. PMID: 28476288 Free article. Clinical Trial.

6

Higher pulse pressure/stroke volume index is associated with impaired outcome in hypertensive patients with left ventricular hypertrophy the LIFE study.

Mancusi C, Gerdts E, de Simone G, Midtbø H, Lønnebakken MT, Boman K, Wachtell K, Dahlöf B, Devereux RB. Mancusi C, et al. Among authors: dahlof b. Blood Press. 2017 Jun;26(3):150-155. doi: 10.1080/08037051.2016.1243009. Epub 2016 Nov 24. Blood Press. 2017. PMID: 27710139 Free article. Clinical Trial.

7

Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy.

Weber MA, Bloch M, Bakris GL, Weir MR, Zappe DH, Dahlof B, Velazquez EJ, Pitt B, Basile JN, Jamerson K, Hua TA. Weber MA, et al. Among authors: dahlof b. J Clin Hypertens (Greenwich). 2016 Apr;18(4):299-307. doi: 10.1111/jch.12816. Epub 2016 Mar 28. J Clin Hypertens (Greenwich). 2016. PMID: 27060568 Free PMC article.

8

Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice.

Schwengel K, Namsolleck P, Lucht K, Clausen BH, Lambertsen KL, Valero-Esquitino V, Thöne-Reineke C, Müller S, Widdop RE, Denton KM, Horiuchi M, Iwai M, Boato F, Dahlöf B, Hallberg A, Unger T, Steckelings UM. Schwengel K, et al. Among authors: dahlof b. J Mol Med (Berl). 2016 Aug;94(8):957-66. doi: 10.1007/s00109-016-1406-3. Epub 2016 Mar 16. J Mol Med (Berl). 2016. PMID: 26983606

9

Physical activity and exercise lower blood pressure in individuals with hypertension: narrative review of 27 RCTs.

Börjesson M, Onerup A, Lundqvist S, Dahlöf B. Börjesson M, et al. Among authors: dahlof b. Br J Sports Med. 2016 Mar;50(6):356-61. doi: 10.1136/bjsports-2015-095786. Epub 2016 Jan 19. Br J Sports Med. 2016. PMID: 26787705 Review.

10

[Aerobic physical activity lowers blood pressure in hypertension].

Börjesson M, Onerup A, Lundqvist S, Dahlöf B. Börjesson M, et al. Among authors: dahlof b. Lakartidningen. 2015 Nov 17;112:DRAI. Lakartidningen. 2015. PMID: 26574809 Free article. Review. Swedish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

384 results

Results by year